BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 11892693)

  • 1. Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or polyarthritis.
    Kotaniemi K; Kotaniemi A; Savolainen A
    Clin Exp Rheumatol; 2002; 20(1):109-12. PubMed ID: 11892693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study.
    Kotaniemi K; Kautiainen H; Karma A; Aho K
    Ophthalmology; 2001 Nov; 108(11):2071-5. PubMed ID: 11713082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center.
    Çakan M; Aktay-Ayaz N; Keskindemirci G; Ekinci DY; Karadağ ŞG
    Turk J Pediatr; 2017; 59(5):548-554. PubMed ID: 29745116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female sex and oligoarthritis category are not risk factors for uveitis in Italian children with juvenile idiopathic arthritis.
    Calandra S; Gallo MC; Consolaro A; Pistorio A; Lattanzi B; Bovis F; Muratore V; De Marco R; Martini A; Ravelli A
    J Rheumatol; 2014 Jul; 41(7):1416-25. PubMed ID: 24931957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis.
    Leinonen S
    Acta Ophthalmol; 2023 Jun; 101(4):465-468. PubMed ID: 36458735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease of the year: juvenile idiopathic arthritis-associated uveitis--classification and diagnostic approach.
    Tugal-Tutkun I; Quartier P; Bodaghi B
    Ocul Immunol Inflamm; 2014 Feb; 22(1):56-63. PubMed ID: 24410427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
    Papadopoulou M; Zetterberg M; Oskarsdottir S; Andersson Grönlund M
    Acta Ophthalmol; 2017 Nov; 95(7):741-747. PubMed ID: 28205413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.
    Lee JJY; Duffy CM; Guzman J; Oen K; Barrowman N; Rosenberg AM; Shiff NJ; Boire G; Stringer E; Spiegel L; Morishita KA; Lang B; Reddy D; Huber AM; Cabral DA; Feldman BM; Yeung RSM; Tucker LB; Watanabe Duffy K;
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1436-1443. PubMed ID: 30320957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline.
    Sim KT; Venning HE; Barrett S; Gregson RM; Amoaku WM
    Ocul Immunol Inflamm; 2006 Dec; 14(6):353-7. PubMed ID: 17162606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and characteristics of uveitis associated with juvenile idiopathic arthritis in Japan: first report of the pediatric rheumatology association of Japan (PRAJ).
    Yasumura J; Yashiro M; Okamoto N; Shabana K; Umebayashi H; Iwata N; Okura Y; Kubota T; Shimizu M; Tomiita M; Nakagishi Y; Nishimura K; Hara R; Mizuta M; Yasumi T; Yamaide F; Wakiguchi H; Kobayashi M; Mori M
    Pediatr Rheumatol Online J; 2019 Apr; 17(1):15. PubMed ID: 30975163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and External Validation of a Model Predicting New-Onset Chronic Uveitis at Different Disease Durations in Juvenile Idiopathic Arthritis.
    van Straalen JW; Kearsley-Fleet L; Klotsche J; de Roock S; Minden K; Heiligenhaus A; Hyrich KL; de Boer JH; Lamot L; Olivieri AN; Gallizzi R; Smolewska E; Faugier E; Pastore S; Hashkes PJ; Herrera CN; Emminger W; Consolini R; Wulffraat NM; Ruperto N; Swart JF;
    Arthritis Rheumatol; 2023 Feb; 75(2):318-327. PubMed ID: 36054539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).
    Foeldvari I; Klotsche J; Simonini G; Edelsten C; Angeles-Han ST; Bangsgaard R; de Boer J; Brumm G; Torrent RB; Constantin T; DeLibero C; Diaz J; Gerloni VM; Guedes M; Heiligenhaus A; Kotaniemi K; Leinonen S; Minden K; Miranda V; Miserocchi E; Nielsen S; Niewerth M; Pontikaki I; de Vicuna CG; Zilhao C; Yeh S; Anton J
    Pediatr Rheumatol Online J; 2019 Oct; 17(1):66. PubMed ID: 31575380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
    Haasnoot AJ; van Tent-Hoeve M; Wulffraat NM; Schalij-Delfos NE; Los LI; Armbrust W; Zuithoff NP; de Boer JH
    Am J Ophthalmol; 2015 Feb; 159(2):372-7.e1. PubMed ID: 25447121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for juvenile idiopathic arthritis associated uveitis with laser flare photometry in the pediatric rheumatology office: a prospective observational study.
    Ede K; Shishov M; Wershba E; Goswami N; Gorry S; Joseph M; Mirea L; O'Neil J
    Pediatr Rheumatol Online J; 2024 Jan; 22(1):22. PubMed ID: 38279120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and Identification of Risk Factors of Uveitis in Juvenile Idiopathic Arthritis: A Long-term Follow-up Study in a Cohort of Italian Children.
    Conti G; Chirico V; Porcaro F; Fede C; Vitale A; Fede A; Castagna I; Fede C
    J Clin Rheumatol; 2020 Oct; 26(7):285-288. PubMed ID: 31609817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.
    van Straalen JW; Giancane G; Amazrhar Y; Tzaribachev N; Lazar C; Uziel Y; Telcharova-Mihaylovska A; Len CA; Miniaci A; Boteanu AL; Filocamo G; Mastri MV; Arkachaisri T; Magnolia MG; Hoppenreijs E; de Roock S; Wulffraat NM; Ruperto N; Swart JF;
    Rheumatology (Oxford); 2021 Jun; 60(6):2896-2905. PubMed ID: 33274366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
    Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
    Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.